|
National Stock Number(NSN): 6505-01-047-3875 (6505010473875, 010473875)
| NIIN: |
01-047-3875 |
Item Name: |
DOCUSATE SODIUM CAPSULES |
INC: |
34179
|
| FSC: |
6505
|
Assignment Date: |
Sep-07-1977 |
CRIT: |
X |
IIG: |
34179 |
| ISC: |
5 |
Date Standardized: |
Sep-07-1977 |
HMIC: |
P |
DODIC: |
|
| NSC: |
4 |
Cancellation Date: |
Oct-22-2024 |
PMIC: |
A |
FIIG: |
A510U0 |
| ESD: |
|
Schedule B: |
3004.90.9250 |
DEMIL: |
A |
DEMIL INT: |
1 |
| TIIC: |
1 |
Originator: |
97 |
ADPEC: |
|
RPDMRC: |
|
| Part Number |
CAGE |
Company |
Status |
RN CC |
RN VC |
DAC |
RN AAC |
RN FC |
RN SC |
RN JC |
SADC |
HCC |
MSDS |
|
0037575 |
0SB26
|
RUGBY LABORATORIES INC CONTRACT DEPT |
H |
3 |
2 |
4 |
ZZ |
|
|
|
|
|
|
|
BU-LAX |
13266
|
ULMER PHARMACAL CO DIV OF JAMES PHILLIPS CO |
H |
5 |
9 |
6 |
54 |
4 |
B |
|
|
|
|
|
NDC00127-1165-01 |
13266
|
ULMER PHARMACAL CO DIV OF JAMES PHILLIPS CO |
H |
5 |
9 |
6 |
54 |
1 |
B |
|
|
|
|
|
NDC00143-3133-01 |
32655
|
HIKMA PHARMACEUTICALS USA INC. |
H |
3 |
2 |
|
|
|
|
|
|
|
|
|
NDC00182-0182-01 |
2U436
|
GOLDLINE LABORATORIES GOVERNMENT SALES DIV |
H |
3 |
2 |
6 |
54 |
|
|
|
|
|
|
|
NDC00536-3757-01 |
4V824
|
RUGBY GROUP INC |
H |
5 |
9 |
6 |
54 |
|
B |
|
|
|
|
Technical Characteristics Information
| MRC |
Requirement Statement |
Reply Statement |
| AKJA |
ACTIVE MEDICAMENT MEDICINAL STRENGTH |
250.000 MILLIGRAMS DOCUSATE SODIUM ACTIVE INGREDIENT |
| AKJC |
CAPSULE TYPE |
SOFT |
| CQCT |
PRIMARY CONTAINER TYPE |
BOTTLE |
| CQLS |
CAPSULE CONTENT FORM |
SOLUTION |
| CSGS |
ADMINISTRATION |
ORAL |
| CYLZ |
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY |
100.000 |
| MDES |
MEDICAL DESIGNATION AND GRADE |
UNITED STATES PHARMACOPEIA |
| MOE Rule |
Former MOER |
Effective |
AMC |
AMSC |
IMC |
IMCA |
Collaborators |
Receivers |
| V540 |
|
Apr-01-1991 |
0 |
0 |
|
|
54 |
54 |
Replacement & Obsolete Information
| Obsolete NIIN Information |
|